Download Now

Your Token Count

0

Sign in to Purchase/Download Documents

Sign in / Register

User login

Social Networking

Support Free Media

Lentinan

Member Page View Enabled

You are currently viewing this page as a full fledged member! If you would like all pages to display this detail of information and wish to sign up for a membership, please click here

User Options

Download a PDF Document of this page with up to the first 50 articles

Request us to build a Downloadable Document Product on this Topic

Make a Request for GMI to add more Articles on this Topic Immediately (Purchase Required)

View a Printer Friendly version of this page

E-mail this page to a friend

Perform a Search with this Topic

Hover over an icon for more information

Additional Topics Details for this Page

Article Count - 8
Cumulative Knowledge - 54

Advanced Database Options

Limit Articles Displayed by the Following Study Types

Available Sorting Options

Limited to Members Only

By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process.

Currently Available Sorting Options

Article Published Date - Sort all displayed articles by their published date
Quick Summary Fieldsets - Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge - Default sorting method. Allows you to sort descendingly

Additional Research

What is Cumulative Knowledge?

Cumulative Knowledge is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.

Click here for a more thorough explanation.

Quick Summary: 10 associated Diseases

Name	Cumulative Knowledge	Article Count	Focus Articles
Colorectal Cancer	10	1	Log in \| Sign up
Gastric Cancer	10	1	Log in \| Sign up
Liver Cancer	10	1	Log in \| Sign up
Pancreatic Cancer	10	1	Log in \| Sign up
Quality of Life: Poor	10	1	Log in \| Sign up
Stomach Cancer	10	1	Log in \| Sign up
Malaria	3	2	Log in \| Sign up
Colon Cancer	2	1	Log in \| Sign up
Immune Disorders: Low Immune Function	2	1	Log in \| Sign up
Low Disorders: Low TH1	2	1	Log in \| Sign up

Quick Summary: 2 associated Pharmacological Actions

Name	Cumulative Knowledge	Article Count	Focus Articles
Interleukin-12 upregulation	2	1	Log in \| Sign up
Antimalarials	1	1	Log in \| Sign up

View the Evidence: Substances

A superfine and dispersed form of beta-glucan (lentinan) is safe and effective for advanced patients' survival and improvement of quality of life.

Click here to read the entire abstract

Pubmed Data : Hepatogastroenterology. 1990 Feb;37(1):72-80. PMID: 19453066

Article Published Date : Feb 01, 1990

Study Type : Human Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8)

Diseases : Pancreatic Cancer : CK(530) : AC(168)

Beta glucan (lentinan) significantly increases survival time in patients treated for stomach cancer.

Click here to read the entire abstract

Pubmed Data : Cancer Detect Prev Suppl. 1987;1:333-49. PMID: 3121179

Article Published Date : Jan 01, 1987

Study Type : Human Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8)

Diseases : Stomach Cancer : CK(373) : AC(20)

Additional Keywords : Drug-Plant-Vitamin Synergies : CK(1011) : AC(268)

Beta glucan is effective in prolonging survival of liver cancer patients.

Click here to read the entire abstract

Pubmed Data : Hepatogastroenterology. 2009 Mar-Apr;56(90):437-41. PMID: 19579616

Article Published Date : Mar 01, 2009

Study Type : Human Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8)

Diseases : Liver Cancer : CK(1641) : AC(266)

Beta glucan is safe and effective for suppressing the adverse effects of chemotherapy and improving quality of life in patients with colorectal cancer.

Click here to read the entire abstract

Pubmed Data : Anticancer Res. 2009 Jul;29(7):2611-7. PMID: 19596936

Article Published Date : Jul 01, 2009

Study Type : Human Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8)

Diseases : Colorectal Cancer : CK(877) : AC(321)

Beta glucan prolongs survival time and improves quality of life in gastric cancer patients.

Click here to read the entire abstract

Pubmed Data : Planta Med. 1990 Aug;56(4):360-3. PMID: 10522061

Article Published Date : Aug 01, 1990

Study Type : Human Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8)

Diseases : Gastric Cancer : CK(373) : AC(111), Quality of Life: Poor : CK(170) : AC(16)

Lentinan from shiitake mushrooms (Lentinus edodes) inhibits of human colon cancer cells.

Click here to read the entire abstract

Pubmed Data : J Altern Complement Med. 2002 Oct;8(5):581-9. PMID: 12470439

Article Published Date : Oct 01, 2002

Study Type : Animal Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8), Shiitake Mushroom : CK(24) : AC(17)

Diseases : Colon Cancer : CK(895) : AC(233)

Additional Keywords : Antineoplastic Agents : CK(69) : AC(28)

The shiitake mushroom-derived immuno-stimulant lentinan (beta-glucan) protects against murine malaria blood-stage infection by evoking adaptive immune-responses.

Click here to read the entire abstract

Pubmed Data : Helicobacter. 2005 Apr;10(2):139-45. PMID: 19189863

Article Published Date : Apr 01, 2005

Study Type : Animal Study

Additional Links

Substances : Beta-glucan : CK(225) : AC(40), Lentinan : CK(55) : AC(8)

Diseases : Immune Disorders: Low Immune Function : CK(488) : AC(115), Low Disorders: Low TH1 : CK(6) : AC(4), Malaria : CK(55) : AC(25)

Pharmacological Actions : Interleukin-12 upregulation : CK(17) : AC(5)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version